EcoDrugPlus

Androgen Receptor

Ensembl ID : ENSCMIG00000017264
Gene Symbol: AR
3 Cross references
277 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCMIG00000010710
Gene Symbol: AGTR1
4 Cross references
214 Possible Orthologues:

Anti-Apoptotic Protein Nr13-Like

Ensembl ID : ENSCMIG00000019349
Gene Symbol: LOC103186861
3 Cross references
129 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSCMIG00000011073
Gene Symbol: APH1A
1 Cross references
131 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSCMIG00000006934
Gene Symbol: APH1B
4 Cross references
186 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSCMIG00000018676
Gene Symbol: ALOX5
4 Cross references
223 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSCMIG00000019271
Gene Symbol: ALOX5AP
4 Cross references
201 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSCMIG00000007929
Gene Symbol: LOC103190915
3 Cross references
200 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSCMIG00000007935
Gene Symbol: AVPR1A
3 Cross references
268 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSCMIG00000014175
Gene Symbol: AVPR1B
4 Cross references
138 Possible Orthologues:

Aromatase

Ensembl ID : ENSCMIG00000019325
Gene Symbol: LOC103186779
3 Cross references
319 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSCMIG00000013921
Gene Symbol: AURKA
3 Cross references
236 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).